Douglass Hanly Moir (DHM) Pathology
Industry / private company
Location:
Sydney,
Australia (AU)
ISNI: 0000000406312320
ROR: https://ror.org/0277g6a74
Show on Map:
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) (2022)
Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin MB, Boudova L, Calio A, et al.
Journal article
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma (2022)
Koch R, Gelderblom H, Haveman L, Brichard B, Jürgens H, Cyprova S, Van Den Berg H, et al.
Journal article
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma (2018)
Ohe C, Smith SC, Sirohi D, Divatia M, De Peralta-Venturina M, Paner GP, Agaimy A, et al.
Journal article
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (2016)
Trpkov K, Hes O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, Kristiansen G, et al.
Journal article
Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma (2016)
Smith SC, Trpkov K, Chen YB, Mehra R, Sirohi D, Ohe C, Cani AK, et al.
Journal article
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients (2014)
Gill AJ, Hes O, Papathomas T, Sedivcova M, Tan PH, Agaimy A, Andresen PA, et al.
Journal article